Literature DB >> 27687058

Claudin-1 Protein Expression Is a Good Prognostic Factor in Non-Small Cell Lung Cancer, but only in Squamous Cell Carcinoma Cases.

Judit Moldvay1,2, Katalin Fábián3, Márta Jäckel4, Zsuzsanna Németh5, Krisztina Bogos6, József Furák7, László Tiszlavicz8, János Fillinger9, Balázs Döme6,10,11, Zsuzsa Schaff12.   

Abstract

The aim of the study was to investigate the correlation between claudin (CLDN) protein expression and clinicopathological parameters as well as survival in histological subtypes of non-small cell lung cancer. Archived surgical resection specimens of 137 pathologic stage I primary bronchial cancers including 49 adenocarcinomas of non-lepidic variants (ADC), 46 adenocarcinomas of lepidic variants (L-ADC), and 42 squamous cell carcinomas (SCC) were examined. Immunohistochemistry (IHC) using antibodies against CLDN1,-2,-3,-4,-7 proteins as well as semiquantitative estimation (IHC scores 0-5) were performed. Claudin IHC scores of L-ADC differed significantly from ADC (CLDN1: p = 0.009, CLDN2: p = 0.005, CLDN3: p = 0.004, CLDN4: p = 0.001, CLDN7: p < 0.001, respectively) and SCC (CLDN1: p < 0.001, CLDN3: p < 0.001, CLDN7: p < 0.001, respectively). Highly significant CLDN3-CLDN4 parallel expression could be demonstrated in ADC and L-ADC (p < 0.001 in both), which was not observed in SCC (p = 0.131). ADC and SCC showed no correlation with smoking, whereas in case of L-ADC heavier smoking correlated with higher CLDN3 expression (p = 0.020). Regarding claudin expression and survival, in SCC significant correlation could be demonstrated between CLDN1 IHC positivity and better survival (p = 0.038). In NSCLC as a whole, high CLDN2 expression proved to be a better prognostic factor when compared with cases where CLDN2 IHC score was 0-1 vs. 2-5 (p = 0.009), however, when analyzed separately, none of the histological subgroups showed correlation between CLDN2 expression and overall survival. The claudin expression pattern was significantly different not only between the SCC-ADC and SCC-L-ADC but also between the L-ADC and ADC histological subgroups, which strongly underlines that L-ADC represents a distinct entity within the ADC group. CLDN1 overexpression is a good prognostic factor in NSCLC, but only in the SCC subgroup.

Entities:  

Keywords:  Claudin; Immunohistochemistry; Lung cancer; Survival

Mesh:

Substances:

Year:  2016        PMID: 27687058     DOI: 10.1007/s12253-016-0115-0

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  21 in total

1.  Expression pattern and prognostic significance of claudins 1, 4, and 7 in nasopharyngeal carcinoma.

Authors:  Chuen Hsueh; Yu-Sun Chang; Ngan-Ming Tseng; Chun-Ta Liao; Swei Hsueh; Jui-Hung Chang; I-Chin Wu; Kai-Ping Chang
Journal:  Hum Pathol       Date:  2010-03-23       Impact factor: 3.466

2.  Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.

Authors:  Scott L Kominsky; Pedram Argani; Dorian Korz; Ella Evron; Venu Raman; Elizabeth Garrett; Alan Rein; Guido Sauter; Olli-P Kallioniemi; Saraswati Sukumar
Journal:  Oncogene       Date:  2003-04-03       Impact factor: 9.867

3.  Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.

Authors:  Akihiko Yoshizawa; Shinji Sumiyoshi; Makoto Sonobe; Masashi Kobayashi; Masakazu Fujimoto; Fumi Kawakami; Tatsuaki Tsuruyama; William D Travis; Hiroshi Date; Hironori Haga
Journal:  J Thorac Oncol       Date:  2013-01       Impact factor: 15.609

4.  Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma.

Authors:  Yu-Chih Chao; Szu-Hua Pan; Shuenn-Chen Yang; Sung-Liang Yu; Ting-Fang Che; Chung-Wu Lin; Mu-Shiun Tsai; Gee-Chen Chang; Che-Hsiang Wu; Yi-Ying Wu; Yung-Chie Lee; Tse-Ming Hong; Pan-Chyr Yang
Journal:  Am J Respir Crit Care Med       Date:  2008-09-11       Impact factor: 21.405

5.  Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study.

Authors:  Murray B Resnick; Tamako Konkin; Justin Routhier; Edmond Sabo; Victor E Pricolo
Journal:  Mod Pathol       Date:  2005-04       Impact factor: 7.842

Review 6.  New pathologic classification of lung cancer: relevance for clinical practice and clinical trials.

Authors:  William D Travis; Elisabeth Brambilla; Gregory J Riely
Journal:  J Clin Oncol       Date:  2013-02-11       Impact factor: 44.544

7.  beta-catenin expression and claudin expression pattern as prognostic factors of prostatic cancer progression.

Authors:  Attila M Szász; Péter Nyirády; Attila Majoros; Attila Szendrõi; Miklós Szûcs; Eszter Székely; Anna-Mária Tõkés; Imre Romics; Janina Kulka
Journal:  BJU Int       Date:  2009-10-10       Impact factor: 5.588

8.  Distinct claudin expression profile in histologic subtypes of lung cancer.

Authors:  Judit Moldvay; Márta Jäckel; Csilla Páska; Ibolya Soltész; Zsuzsa Schaff; András Kiss
Journal:  Lung Cancer       Date:  2007-04-06       Impact factor: 5.705

9.  Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma.

Authors:  Zhenfa Zhang; Anlei Wang; Bingsheng Sun; Zhongli Zhan; Kexin Chen; Changli Wang
Journal:  J Cardiothorac Surg       Date:  2013-04-16       Impact factor: 1.637

10.  Up-regulation of CLDN1 in gastric cancer is correlated with reduced survival.

Authors:  Lars L Eftang; Ying Esbensen; Tone M Tannæs; Gustav P Blom; Ida R K Bukholm; Geir Bukholm
Journal:  BMC Cancer       Date:  2013-12-10       Impact factor: 4.430

View more
  10 in total

1.  Comprehensive Diagnostic Medical System Based on Notch1 Signaling Pathway to Inhibit the Growth of Small-Cell Lung Carcinoma.

Authors:  Xiaoli Zhang; Ziying Yu
Journal:  J Healthc Eng       Date:  2022-05-19       Impact factor: 3.822

2.  Claudin-3 Inhibits Lung Squamous Cell Carcinoma Cell Epithelial-mesenchymal Transition and Invasion via Suppression of the Wnt/β-catenin Signaling Pathway.

Authors:  Juanjuan Che; Dongsheng Yue; Bin Zhang; Hua Zhang; Yansong Huo; Liuwei Gao; Hongchao Zhen; Yan Yang; Bangwei Cao
Journal:  Int J Med Sci       Date:  2018-02-05       Impact factor: 3.738

3.  CLDN1 Increases Drug Resistance of Non-Small Cell Lung Cancer by Activating Autophagy via Up-Regulation of ULK1 Phosphorylation.

Authors:  Zhenhuan Zhao; Jing Li; Yan Jiang; Wen Xu; Xin Li; Weili Jing
Journal:  Med Sci Monit       Date:  2017-06-14

4.  Long non-coding RNA linc01433 promotes migration and invasion in non-small cell lung cancer.

Authors:  Banglun Qian; Xiang Wang; Chao Mao; Yiqun Jiang; Ying Shi; Ling Chen; Shuang Liu; Bin Wang; Shu Pan; Yongguang Tao; Hongcan Shi
Journal:  Thorac Cancer       Date:  2018-03-13       Impact factor: 3.500

5.  Molecular profiling identifies prognostic markers of stage IA lung adenocarcinoma.

Authors:  Jie Zhang; Jinchen Shao; Lei Zhu; Ruiying Zhao; Jie Xing; Jun Wang; Xiaohui Guo; Shichun Tu; Baohui Han; Keke Yu
Journal:  Oncotarget       Date:  2017-08-24

6.  All Benign and Malignant Apocrine Breast Lesions Over-Express Claudin 1 and 3 and Are Negative for Claudin 4.

Authors:  Sami Shousha; Oliver Anscombe; Taneisha McFarlane
Journal:  Pathol Oncol Res       Date:  2019-05-01       Impact factor: 3.201

7.  E7 oncoprotein from human papillomavirus 16 alters claudins expression and the sealing of epithelial tight junctions.

Authors:  Perla Yaceli Uc; Jael Miranda; Arturo Raya-Sandino; Lourdes Alarcón; María Luisa Roldán; Rodolfo Ocadiz-Delgado; Enoc Mariano Cortés-Malagón; Bibiana Chávez-Munguía; Georgina Ramírez; René Asomoza; Liora Shoshani; Patricio Gariglio; Lorenza González-Mariscal
Journal:  Int J Oncol       Date:  2020-07-29       Impact factor: 5.650

8.  Cell cycle-related and expression-elevated protein in tumor overexpression is associated with proliferation behaviors and poor prognosis in non-small-cell lung cancer.

Authors:  Weimiao Li; Guoxu Zheng; Jinghua Xia; Guang Yang; Jianyong Sun; Xuejiao Wang; Miaomiao Wen; Ying Sun; Zhipei Zhang; Faguang Jin
Journal:  Cancer Sci       Date:  2018-03-05       Impact factor: 6.716

9.  Regulatory Network Analysis to Reveal Important miRNAs and Genes in Non-Small Cell Lung Cancer.

Authors:  Xingni Zhou; Zhenghua Zhang; Xiaohua Liang
Journal:  Cell J       Date:  2019-07-29       Impact factor: 2.479

10.  Claudin-1 silencing increases sensitivity of liver cancer HepG2 cells to 5-fluorouracil by inhibiting autophagy.

Authors:  Hui Tong; Tao Li; Weihua Qiu; Zhecheng Zhu
Journal:  Oncol Lett       Date:  2019-10-08       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.